Cargando…
Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COV...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342850/ https://www.ncbi.nlm.nih.gov/pubmed/32641368 http://dx.doi.org/10.1136/bmjopen-2020-039120 |
_version_ | 1783555607929815040 |
---|---|
author | Byrne, James D Wentworth, Adam J Chai, Peter R Huang, Hen-Wei Babaee, Sahab Li, Canchen Becker, Sarah L Tov, Caitlynn Min, Seokkee Traverso, Giovanni |
author_facet | Byrne, James D Wentworth, Adam J Chai, Peter R Huang, Hen-Wei Babaee, Sahab Li, Canchen Becker, Sarah L Tov, Caitlynn Min, Seokkee Traverso, Giovanni |
author_sort | Byrne, James D |
collection | PubMed |
description | OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COVID-19 pandemic. DESIGN: Single-arm feasibility study. SETTING: Emergency department and outpatient oncology clinic. PARTICIPANTS: Healthcare workers who have previously undergone N95 fit testing. INTERVENTIONS: Fit testing of new iMASC system. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome is success of fit testing using an Occupational Safety and Health Administration (OSHA)-approved testing method, and secondary outcomes are user experience with fit, breathability and filter replacement. RESULTS: Twenty-four subjects were recruited to undergo fit testing, and the average age of subjects was 41 years (range of 21–65 years) with an average body mass index of 26.5 kg/m(2). The breakdown of participants by profession was 46% nurses (n=11), 21% attending physicians (n=5), 21% resident physicians (n=5) and 12% technicians (n=3). Of these participants, four did not perform the fit testing due to the inability to detect saccharin solution on premask placement sensitivity test, lack of time and inability to place mask over hair. All participants (n=20) who performed the fit test were successfully fitted for the iMASC system using an OSHA-approved testing method. User experience with the iMASC system, as evaluated using a Likert scale with a score of 1 indicating excellent and a score of 5 indicating very poor, demonstrated an average fit score of 1.75, breathability of 1.6, and ease of replacing the filter on the mask was scored on average as 2.05. CONCLUSIONS: The iMASC system was shown to successfully fit multiple different face sizes and shapes using an OSHA-approved testing method. These data support further certification testing needed for use in the healthcare setting. |
format | Online Article Text |
id | pubmed-7342850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73428502020-07-09 Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study Byrne, James D Wentworth, Adam J Chai, Peter R Huang, Hen-Wei Babaee, Sahab Li, Canchen Becker, Sarah L Tov, Caitlynn Min, Seokkee Traverso, Giovanni BMJ Open Global Health OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COVID-19 pandemic. DESIGN: Single-arm feasibility study. SETTING: Emergency department and outpatient oncology clinic. PARTICIPANTS: Healthcare workers who have previously undergone N95 fit testing. INTERVENTIONS: Fit testing of new iMASC system. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome is success of fit testing using an Occupational Safety and Health Administration (OSHA)-approved testing method, and secondary outcomes are user experience with fit, breathability and filter replacement. RESULTS: Twenty-four subjects were recruited to undergo fit testing, and the average age of subjects was 41 years (range of 21–65 years) with an average body mass index of 26.5 kg/m(2). The breakdown of participants by profession was 46% nurses (n=11), 21% attending physicians (n=5), 21% resident physicians (n=5) and 12% technicians (n=3). Of these participants, four did not perform the fit testing due to the inability to detect saccharin solution on premask placement sensitivity test, lack of time and inability to place mask over hair. All participants (n=20) who performed the fit test were successfully fitted for the iMASC system using an OSHA-approved testing method. User experience with the iMASC system, as evaluated using a Likert scale with a score of 1 indicating excellent and a score of 5 indicating very poor, demonstrated an average fit score of 1.75, breathability of 1.6, and ease of replacing the filter on the mask was scored on average as 2.05. CONCLUSIONS: The iMASC system was shown to successfully fit multiple different face sizes and shapes using an OSHA-approved testing method. These data support further certification testing needed for use in the healthcare setting. BMJ Publishing Group 2020-07-07 /pmc/articles/PMC7342850/ /pubmed/32641368 http://dx.doi.org/10.1136/bmjopen-2020-039120 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Global Health Byrne, James D Wentworth, Adam J Chai, Peter R Huang, Hen-Wei Babaee, Sahab Li, Canchen Becker, Sarah L Tov, Caitlynn Min, Seokkee Traverso, Giovanni Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title | Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title_full | Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title_fullStr | Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title_full_unstemmed | Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title_short | Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study |
title_sort | injection molded autoclavable, scalable, conformable (imasc) system for aerosol-based protection: a prospective single-arm feasibility study |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342850/ https://www.ncbi.nlm.nih.gov/pubmed/32641368 http://dx.doi.org/10.1136/bmjopen-2020-039120 |
work_keys_str_mv | AT byrnejamesd injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT wentworthadamj injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT chaipeterr injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT huanghenwei injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT babaeesahab injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT licanchen injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT beckersarahl injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT tovcaitlynn injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT minseokkee injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy AT traversogiovanni injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy |